IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
9.77
+0.23 (2.36%)
Nov 20, 2024, 4:00 PM EST - Market closed
IGM Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 2.92 | 2.13 | 1.07 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 57.64% | 99.25% | - | - | - | - | Upgrade
|
| Cost of Revenue | 184.38 | 213.79 | 179.29 | 127.03 | 65.03 | - | Upgrade
|
| Gross Profit | -181.46 | -211.66 | -178.22 | -127.03 | -65.03 | - | Upgrade
|
| Selling, General & Admin | 51.43 | 49.98 | 49.74 | 38.3 | 18.25 | 9.24 | Upgrade
|
| Research & Development | - | - | - | - | - | 35.26 | Upgrade
|
| Operating Expenses | 51.43 | 49.98 | 49.74 | 38.3 | 18.25 | 44.5 | Upgrade
|
| Operating Income | -232.89 | -261.64 | -227.96 | -165.32 | -83.28 | -44.5 | Upgrade
|
| Interest & Investment Income | 15.12 | 17.74 | 7.04 | 0.16 | 1.93 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.99 | -9.16 | -2.89 | 0.62 | - | 1.06 | Upgrade
|
| EBT Excluding Unusual Items | -219.76 | -253.05 | -223.82 | -164.54 | -81.36 | -43.44 | Upgrade
|
| Merger & Restructuring Charges | -1.83 | -1.83 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.99 | 9.14 | 2.71 | -0.62 | - | 0.31 | Upgrade
|
| Pretax Income | -219.6 | -245.74 | -221.1 | -165.16 | -81.36 | -43.13 | Upgrade
|
| Income Tax Expense | 0.24 | 0.68 | - | - | - | - | Upgrade
|
| Net Income | -219.84 | -246.42 | -221.1 | -165.16 | -81.36 | -43.13 | Upgrade
|
| Net Income to Common | -219.84 | -246.42 | -221.1 | -165.16 | -81.36 | -43.13 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 52 | 42 | 33 | 31 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 52 | 42 | 33 | 31 | 9 | Upgrade
|
| Shares Change (YoY) | 24.54% | 25.92% | 24.09% | 8.88% | 241.82% | 1953.40% | Upgrade
|
| EPS (Basic) | -3.65 | -4.71 | -5.32 | -4.93 | -2.65 | -4.80 | Upgrade
|
| EPS (Diluted) | -3.65 | -4.71 | -5.32 | -4.93 | -2.65 | -4.80 | Upgrade
|
| Free Cash Flow | -172.62 | -204.61 | -16.06 | -138.23 | -85.38 | -47.45 | Upgrade
|
| Free Cash Flow Per Share | -2.86 | -3.91 | -0.39 | -4.13 | -2.78 | -5.28 | Upgrade
|
| Operating Margin | -7981.25% | -12283.33% | -21324.23% | - | - | - | Upgrade
|
| Profit Margin | -7534.03% | -11568.83% | -20683.07% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -5915.76% | -9606.20% | -1502.25% | - | - | - | Upgrade
|
| EBITDA | -223.95 | -253.36 | -221.88 | -160.84 | -82.26 | -43.9 | Upgrade
|
| D&A For EBITDA | 8.94 | 8.28 | 6.08 | 4.48 | 1.03 | 0.6 | Upgrade
|
| EBIT | -232.89 | -261.64 | -227.96 | -165.32 | -83.28 | -44.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.